Windhover
Home
Home		 Register
Register		 Login
Log In		 Schedule
Schedule		 Information
Info		 Attending Companies
Attendees		 Contact
Contact		 Help
Help
October 19-21 2009InterContinental Mark HopkinsSan Francisco, CA

October 19, 2009
8:00 - 8:45 AMRegistration and Continental Breakfast
8:45 - 9:00 AMLarge Companies and VCs Talk about What They Look for When Making Investment/Exit Strategy Choices
  • What are the strategic priorities?
  • How active is their deal making?
  • What value are they looking for?
  • Which therapeutic areas is the focus for outside technology sourcing?
  • What are some lessons learned from some of the deals done?
  • To what extent are you looking to buy products rather than companies or vice versa?
  • What’s the relationship or trade-off between deal-making and internal R&D investment?
  • How important a role will acquisitions play for going forward?

    • David Cassak, Managing Director, Medical Devices, Elsevier Business Intelligence
    • 9:00 - 9:15 AMCharles Warden, Managing Director - Versant Ventures
    9:20 - 9:35 AMJohn Onopchenko, Managing Director - Synergy Life Science Partners
    9:40 - 9:55 AMJames A. Datin, Executive Vice President and Managing Director, Life Sciences Group - Safeguard Scientifics, Inc.
    10:00 - 10:15 AMJohn F. Ryan, Partner, Medical Technology - ONSET Ventures
    10:20 - 10:35 AMMark Brooks, Managing Director - Scale Venture Partners
    10:35 - 10:55 AMNetworking Break
    10:55 - 11:00 AMModerator - Medmarc & The Hartford
    11:00 - 11:15 AMScott Halsted, Managing Director - Saints Capital
    11:20 - 11:35 AMKathy Tune, Principal - Thomas, McNerney & Partners
    11:40 - 11:55 AMPeter K. Shagory, Partner - Baird Venture Partners
    12:00 - 12:15 PMChanan Schneider, Managing General Partner - Agate Medical Investments LP
    12:20 - 12:35 PMWalter Lin, MD, Investment Manager - Ascension Health Ventures
    12:40 - 1:55 PMLunch
    2:00 - 3:00 PMWhat are the Large Device Companies Shopping for?
  • What new technology/therapeutic areas do you find promising and interesting in accessing via investment?
  • What are the investing opportunities with large companies?
  • How can companies maximize their visibility in front of larger companies?
  • What role does M&A play at the company?
  • What kind of value are large companies looking for?
    • Chad Cornell, VP, Corporate Development - Medtronic
    • Ted Davis, Vice President, Business Development - Wright Medical Technology
    • Albert Lauritano, MSc, CLP, Director, Business Development - Becton Dickinson
    • Wendelin Maners, VP, Bus. Development/Strategy – Boston Scientific
    3:05 - 3:10 PMModerator - Intertek
    3:10 - 3:25 PMJeani Delagardelle, Managing Director - New Leaf Venture Partners
    3:30 - 3:45 PMMyles Greenberg, M.D., Partner - CHL Medical Partners
    3:50 - 4:05 PMJan Garfinkle, Managing Director - Arboretum Ventures
    4:10 - 4:25 PMRichard Ferrari, Managing Director - De Novo Ventures
    4:30 - 4:45 PMEvan Melrose, Managing Director - PTV Sciences
    4:50 - 5:05 PMStephen Snowdy, PhD, Partner - MB Venture Partners
    5:05 - 7:00 PMPre-Conference Registration and Reception
    6:00 - 7:00 PM Patent Strategies For Medical Device Companies - Case Studies From The Top Medical Device Cases of 2009
  • US Patent Office trends impacting medical device patents
  • Securing and enforcing medical method patents
  • Challenging medical device and method patents
  • Inducement of infringement for medical patents
  • Damages and injunctions for medical patents
    • Joseph F. Jennings, Partner,Knobbe Martens
    • Paul N. Conover, Partner, Knobbe Martens
    • Matt Bellinger, Partner, Knobbe Martens
    • Curtis R. Huffmire, Partner, Knobbe Martens - Moderator
    October 20, 2009
    7:15 - 7:55 AMRegistration and Continental Breakfast
    8:00 - 9:00 AMMedical Device Investing, Financing and Exit Strategies:
    What are the Hot Deals Now and in the Future
  • Real-life case studies of successful financings.
  • How to be successful in the start-up trenches.
  • Where do the deals come from?
  • Why invest in certain technologies and companies and why?
  • How important are valuations at an early stage?
  • How to view niche product technologies?
  • Picks for deals of the year and why: rationale behind investments.
  • Defining a clear path to value creation.
  • How can companies get attention and visibility in front of investors?
  • What kind of due diligence should companies do?
  • How to visualize the exit strategy.
  • Understanding the target audience for your product.
    • Sami Hamade, Partner, Aberdare Ventures
    • Nathan Every, MD, MPH, General Partner, Frazier Healthcare Ventures
    • Glenn Reicin, Venture Partner, Skyline Ventures
    • Scott Wolf, Vice President, Venture Capital, Covidien Ventures
    • Howard D. Palefsky, Managing Director, Montreux Equity Partners
    9:00 - 9:05 AMModerator - The Medtech Group
    9:05 - 9:15 AMMicro-Imaging Solutions
    9:15 - 9:25 AMS.E.A. Medical Systems, Inc.
    9:25 - 9:35 AMNanospectra Biosciences, Inc.
    9:35 - 9:45 AMCoaguSense, Inc.
    9:45 - 9:55 AMFirst Light Biosciences
    9:55 - 10:25 AMOne-on-One Partnering Meetings; Break-out Sessions; Coffee Break
    10:25 - 10:30 AMModerator - Knobbe Martens
    10:30 - 10:40 AMCytoLogic Inc.
    10:40 - 10:50 AMPico-Tesla Magnetic Therapies, LLC
    10:50 - 11:00 AMInterface Biologics
    11:00 - 11:10 AMRegenesis Biomedical, Inc.
    11:10 - 11:20 AMSunshine Heart Inc.
    11:20 - 11:50 AMOne-on-One Partnering Meetings; Break-out Sessions; Coffee Break
    11:50 - 12:50 PMLunch - VC hosted lunch tables
    12:50 - 12:55 PMModerator - C2P Advisors
    12:55 - 1:05 PMEpicardial Technologies Inc.
    1:05 - 1:15 PMVascular Designs, Inc.
    1:15 - 1:25 PMOrthoX, LLC
    1:45 - 1:50 PMOne-on-One Partnering Meetings; Break-out Sessions; Coffee Break
    2:00 - 2:05 PMModerator - Easton Aossciates
    2:05 - 2:15 PMApplied Spine Technologies, Inc.
    2:15 - 2:25 PMSoftscope Medical Technologies
    2:25 - 2:35 PMNeoMatrix, LLC
    2:35 - 2:45 PMEndoscape, Inc.
    2:45 - 2:55 PMActiveO, LLC
    2:55 - 3:25 PMOne-on-One Partnering Meetings; Break-out Sessions; Coffee Break
    3:25 - 3:30 PMModerator - Medtech
    3:30 - 3:40 PMECI Biotech
    3:40 - 3:50 PMSilere Medical Technology, Inc.
    3:50 - 4:00 PMOrthopedic Sciences, Inc.
    4:00 - 4:10 PMInsituvue
    4:10 - 4:20 PMNeoVista, Inc.
    4:20 - 4:50 PMOne-on-One Partnering Meetings; Break-out Sessions; Coffee Break
    4:50 - 4:55 PMModerator - Corvalent
    4:55 - 5:05 PMCardioPolymers, Inc.
    5:05 - 5:15 PMBioscan Technologies, Ltd.
    5:15 - 5:25 PM CorInnova, Inc.
    5:25 - 5:35 PMBiotectix LLC
    5:35 - 5:45 PMAardvark Medical, LLC
    5:45 - 6:15 PMOne-on-One Partnering Meetings; Break-out Sessions; Coffee Break
    6:15 - 7:45 PMInnovator's Product Expo/Networking Reception - Peacock Court
    October 21, 2009
    7:30 - 7:55 AMRegistration and Continental Breakfast - Lobby Terrace
    7:55 - 8:00 AM Moderator - SalesForce4Hire
    8:00 - 8:10 AMBreastCancerInitiative
    8:10 - 8:20 AMStellarray, Inc.
    8:20 - 8:30 AM3C Oncology
    8:30 - 9:00 AMOne-on-One Partnering Meetings; Break-out Sessions; Coffee Break
    9:00 - 9:05 AM Moderator - Schwartz Communications
    9:05 - 9:15 AMMicroPhage, Inc.
    9:15 - 9:25 AMRetina Implant AG
    9:25 - 9:35 AMBioheart, Inc.
    9:35 - 9:45 AMAura Medsystems
    9:45 - 9:55 AMKerecis Limited
    10:00 - 10:30 AMOne-on-One Partnering Meetings; Break-out Sessions; Coffee Break
    10:30 - 10:35 AMModerator –Intertek
    10:35 - 10:45 AMCVAC Systems, Inc
    10:45 - 10:55 AMAvita Medical Ltd.
    10:55 - 11:05 AMPerfint Healthcare Ltd.
    11:05 - 11:15 AMApieron, Inc.
    11:15 - 11:25 AMGraft-Loc
    11:25 - 11:55 AMOne-on-One Partnering Meetings; Break-out Sessions; Coffee Break
    12:00 - 12:45 PMSecuring Reimbursement for Your Innovative Device: True Stories from the Trenches
    You’ve developed a breakthrough device that brilliantly fills an unmet clinical need. Doctors love it, patients want it ... but how do you persuade insurers to pay for it? What are the steps on the path to reimbursement? How long will it take and how much will it cost? What creative strategies are companies pursing to ensure their product gets reimbursed and gains widespread adoption? These are just some of the critical questions that will be discussed during this practical, information-filled session. Find out what your company should be doing now! Learn how to:
  • Plan clinical trials to support reimbursement.
  • Obtain an appropriate CPT code.
  • Build an evidence base that will convince private and public payers
  • Predict and plan for the costs of obtaining reimbursement
  • Find the right experts to help you strategize and be successful
    • Steve Levin, Editor-in-Chief, Medical Devices, Elsevier Business Intelligence (moderator)
    • Debra Reisenthel, CEO, Novasys Medical
    • Michael Klein, CEO, Xoft
    • Allison Shuren, Attorney, Arnold & Porter
    12:45 - 1:00 PMWorking/Box Lunch (please grab a box lunch and return to the conference room)
    1:00 - 1:10 PMGynesonics
    1:10 - 1:20 PM CerMed Corporation
    1:20 - 1:30 PMOrtho Ion
    1:30 - 1:40 PMDiFUSION Technologies
    1:40 - 1:50 PM Calibra Medical Inc.
    1:50 - 2:20 PMOne-on-One Partnering Meetings; Break-out Sessions; Coffee Break
    2:25 - 3:00 PMDealmaking Trends between Device Companies and their Investors:The Year’s Hottest Deals and Rationale behind Them
  • What are some key growth trends for device companies?
  • Which therapeutic focus is the hottest? Which are raising interest levels?
  • Where is the funding going?
  • Who’s doing what and what phase are they in?
  • What is the state of financing, M & A and the IPO market?
  • How are device stocks performing?
  • Which technologies post the best opportunities?
  • What are the new financing models?
  • How are large companies sustaining growth?
    • David Cassak, Managing Director, Medical Devices, Elsevier Business Intelligence
    • Stephen Levin, Executive Editor, Elsevier Business Intelligence
    • Tom Salemi, Senior Writer, Elsevier Business Intelligence
    Presenting Companies
    Locations    		Technologies
    3C Oncology (First-Time Presenter)
    Irvine, CA    		Website 3C Oncology is developing four products enhancing focally delivered radiation and drug therapies for patients with spinal metastatic disease.
    Aardvark Medical, LLC
    Ross, CA     		Website Aardvark Medical has developed a novel, proprietary platform for nasal and sinus care. Aardvark plans to market professional and OTC healthcare devices that diagnose and treat patients with nasal dysfunction.”
    ActiveO, LLC (First-Time Presenter)
    Incline Village, NV    		Website Spine technology company focused on the development and delivery of minimally invasive, image-guided therapies to treat back pain.
    Apieron (First-Time Presenter)
    Menlo Park, CA    		Apieron is a privately-held medical device company with a proprietary device on the market which measures exhaled nitric oxide to determine asthma severity.
    Applied Spine Technologies, Inc.
    New Haven, CT    		Website Applied Spine Technologies, Inc. is developing the Stabilimax NZ®, a posterior dynamic stabilization device designed to support an injured or degenerated spine without eliminating motion.
    Aura Medsystems, Inc.
    New York, NY    		Aura Medsystems is a premier medical device company committed to advancing patient care by focusing on the commercialization of a novel tissue repair platform that obviates the need for sutures, stapes, glues, or other foreign bodies and instead allows the body to repair and heal itself.
    Avita Medical Ltd. (First-Time Presenter)
    Cambridge, United Kingdom    		Website Avita has recently introduced ReCell® Spray-On Skin, rapid, autologous cell harvesting, processing and delivery technology, accelerating healing, minimizing rejection, eliminating scar formation and reintroducing normal pigmentation, vascularisation and innervation in the treated wound area; addresses needs of the burns, wound care, plastics, dermatological and aesthetic markets.
    Bioheart, Inc.
    Sunrise, FL    		Website We are committed to delivering intelligent devices and biologics that monitor, diagnose and treat heart failure and cardiovascular diseases.
    Bioscan Technologies, Ltd. (First-Time Presenter)
    Yokneam, Israel     		Website Bioscan Technologies has developed a novel guidewire-based intravascular ultrasound system (the LightWire™ and ArteroScan™) for use by interventional cardiologists in determining correct stent size on-line during the PCI procedure.
    Biotectix LLC (First-Time Presenter)
    Ann Arbor, MI    		Website Biotectix conducting polymer biomaterials are the catalyst for the next generation of implanted medical device permitting miniaturization, leapfrog gains in device performance, safety, and energy-efficiency, MRI compatibility and reduced device invasiveness.
    Breast Cancer Initiatives (First-Time Presenter)
    Charleston, SC     		Website Early stage medical device company with patent pending transformative technologies for breast cancer detection and treatment.
    Calibra Medical Inc. (First-Time Presenter)
    Redwood City, CA    		Develops a small, wearable, all-mechanical insulin delivery device containing a 3-day supply of insulin that can be actuated through clothing, allowing simple, discreet insulin administration without the need for complicated, programmable pumps.
    CardioPolymers, Inc. (First-Time Presenter)
    Laguna Hills, CA    		Website CardioPolymers, Inc., has developed Algisyl-LVR® a novel biopolymer implant technology intended to prevent or reverse the progression of congestive heart failure in ischemic or idiopathic dilated cardiomyopathy patients. Algisyl-LVR is classified as a medical device.
    CerMed Corporation (First-Time Presenter)
    Monterey, CA     		Website A women’s medical device company with license and multiple internally developed products resulting in immediate revenue featuring unique point of care Paps replacement.
    CoaguSense, Inc. (First-Time Presenter)
    Fremont, CA    		Website CoaguSense is launching a hand-held point-of-care/home testing coagulation PT/INR monitoring system.
    CorInnova, Inc. (First-Time Presenter)
    College Station, TX    		Website Minimally invasive direct cardiac compression device that passively and actively controls the heart’s motion throughout the cardiac cycle.
    CVAC Systems, Inc.
    Temecula, CA    		Website A new, noninvasive modality to treat diabetic neuropathy—a potential $12 billion annual U.S. market
    CytoLogic Inc. (First-Time Presenter)
    Aurora, CO    		CytoLogic is pursuing the development and commercialization of a novel cancer immunotherapy device, which selectively removes specific blood-borne inhibitors of the immune system.
    DiFUSION Technologies (First-Time Presenter)
    Austin, TX    		Website Company Description Coming Soon.
    ECI Biotech
    Worcester, MA    		Website ECI Biotech, Inc. (ECI) is a premier developer and manufacturer of innovative, patented ExpressDetect® Diagnostics products for rapid infection determination for professional as well as consumer markets.
    Endoscape, Inc. (First-Time Presenter)
    Sunnyvale, CA    		Website Endoscape develops low cost disposable devices for solving the colonoscopy pain, efficiency problems and potentially, the colon preparation difficulty. An initial product is close to 510(k) submission and release.
    Epicardial Technologies, Inc. (First-Time Presenter)
    San Clemente, CA    		Website Epicardial Technologies: Pioneering electrophysiology products for epicardial access, visualization and treatment of arrhythmias for large, growing patient population with IP licensed from major universities.
    First Light Biosciences (First-Time Presenter)
    Bedford, MA    		Website First Light is developing rapid, sensitive, and cost-effective diagnostic products for detecting microbes causing hospital associated infections. Advantages include proprietary imaging technology that counts cells and molecules without magnification, walk-away automation, and easy-to-use consumables.
    Graft-Loc
    Englewood, CA    		Website Graft-Loc is a debt-free, early stage device company focused on vascular connections for use in CABG & vascular surgeries. Graft-Loc's patented device creates a reliable anastomosis to any graft site.
    Gynesonics (First-Time Presenter)
    Redwood City, CA    		Website Gynesonics has developed a novel ultrasound guided ablation device to treat symptomatic uterine fibroids through a transcervical approach.
    Insituvue Inc. (First-Time Presenter)
    Irvine, CA    		Hand held Ultrasound device.
    Interface Biologics (First-Time Presenter)
    Toronto, Canada    		Website Develops biomedical polymer technologies that enhance the safety and effectiveness of implantable medical devices by reducing thrombosis, inhibiting infection and providing effective drug delivery.
    Intrapartum LLC (First-Time Presenter)
    Jacksonville, FL     		Website Developed technology which enables an individual to determine with specificity the dilation of a female's cervix during labor by using a disposable glove with embedded sensors which are attached to an external read-out.
    Kerecis Limited (First-Time Presenter)
    Reykjavik, Iceland     		Website Kerecis develops and manufactures tissue repair products for use in a range of reconstructive and orthopedic surgical procedures. The Kerecis technology is based on proprietary marine derived proteins.
    Micro-Imaging Solutions (First-Time Presenter)
    Englewood, CO    		Website Protected technology related to the development and utilization of miniature, high-resolution, low cost CMOS image sensors developed primarily for use in disposable endoscopic surgical applications.
    MicroPhage, Inc. (First-Time Presenter)
    Longmont, CO     		Website Bacteriophage enabling technology that offers the ability to increase specificity and decrease time to results on existing immunodiagnostic platforms.”
    Miracor Medical Systems GmbH (First-Time Presenter)
    Vienna, Austria    		 Website Miracor is founded to develop and commercialize the PICSO™ (Pressure-controlled Intermittent Coronary Sinus Occlusion) technology for acute coronary syndrome (ACS) and heart failure patients. The company holds an extensive patent portfolio and will start its commercialization in Europe.
    Nanospectra Biosciences, Inc.
    Houston, TX    		Website Engaged in the commercialization of AuroLase™ Therapy, a particle-based therapy for the precise thermal destruction of solid tumors.
    NeoMatrix, LLC (First-Time Presenter)
    Irvine, CA    		Website Develops innovative devices that promote optimal breast health.
    NeoVista, Inc
    Fremont, CA    		Website NeoVista, Inc. has a minimally invasive surgical technology that uses ionizing radiation to treat Age-Related Macular Degeneration (ARMD).
    Ortho Ion (First-Time Presenter)
    Migdal HaEmek, Israel    		Ortho Ion has patented a single use, disposable silver ion delivery device to treat Osteomyelitis. The company believes its novel treatment is more effective than current medical therapy, can cut cost by 80% and meets a $4B market opportunity.
    Orthopedic Sciences, Inc. (First-Time Presenter)
    Seal Beach, CA    		Website Later stage company designs, develops and manufactures proprietary medical products for the orthopaedic industry, specifically, musculoskeletal joint preservation and hip arthroscopy.
    OrthoX, LLC (First-Time Presenter)
    Granger, IN    		Website OrthoX is commercializing a high fatigue fiber reinforced bone cement for orthopedic joint replacement.
    Perfint Healthcare Ltd. (First-Time Presenter)
    Chennai, India     		Website Perfint Healthcare, is based in Chennai, India. Launched PIGA CT - A Robotic Assistance device for CT guided interventions of Thorax/Abdomen/Pelvis in Mar ’09. Has since shipped 25 units to top hospitals in India. Raising $8-10M Series B. Current investors : IDG/Accel.
    Pico-Tesla Magnetic Therapies, LLC
    Littleton, CO    		Website Later-stage, web-enabled, non invasive, neuromodulation platform technology company, beginning a phase III Clinical trial (2009) involving Parkinson’s Disease.
    Q-Core Ltd. (First-Time Presenter)
    Petach Tikva, Israel    		Website Research, Development, Manufacture and INNOVATION of infusion pump platforms for today and tomorrow’s electronic drug delivery needs.
    Regenesis Biomedical, Inc. (First-Time Presenter)
    Scottsdale, AZ    		 Website Marketing a device, Provant®, based on pulsed RF energy to trigger tissue regeneration-repair of soft tissues, including skin.
    Retina Implant AG
    Reutlingen, Germany     		Website Retina Implant plans to deliver the first implanted electronic subretinal device, to give back to visually blinds parts of lost sight
    S.E.A. Medical Systems, Inc
    Sunnyvale, CA     		Website Smart IVÔ is the first product to instantaneously report drug and concentration in IV lines alerting healthcare providers to errors which injure or kill hundreds of thousands of patients per year. With billions of IVs administered, the market is huge.
    Silere Medical Technology, Inc.
    Kirkland, WA    		Website Developing its ‘T-Stim’ platform, with the objective to design, manufacture, and bring to market electrical neural stimulators to treat hearing, balance and perceptual disorders.
    Softscope Medical Technologies
    Minnetonka, MN    		 Website Innovative endoscopic assist device designed to significantly improve flexible endoscopy procedures.
    SquareOne, Inc. (First-Time Presenter)
    Mountain View, CA    		SquareOne is commercializing a highly differentiated aorto-ostial stent and delivery platform with strong IP for both peripheral and coronary application.
    Stellarray, Inc. (First-Time Presenter)
    Austin, CA    		Website Stellarray makes and sells flat panel and custom radiation sources that solve problems in sterilization and medical imaging.
    Sunshine Heart Inc.
    Tustin, CA    		Website Cardiac assist device to treat patients in moderate to severe long term heart failure.
    Vascular Designs, Inc.
    San Jose, CA     		Website Catheter for the treatment of non-responsive and unresectable stage IV metastatic colorectal cancer.